Invention Grant
- Patent Title: Clostridium difficile polypeptides as vaccine
-
Application No.: US14425037Application Date: 2013-09-19
-
Publication No.: US09932374B2Publication Date: 2018-04-03
- Inventor: Cesira Galeotti , Rosanna Leuzzi , Mariagrazia Pizza , Maria Scarselli , Meera Unnikrishnan , Manuele Martinelli
- Applicant: GlaxoSmithKline Biologicals SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: GB1216748.2 20120919; GB1216749.0 20120919
- International Application: PCT/IB2013/058673 WO 20130919
- International Announcement: WO2014/045226 WO 20140327
- Main IPC: A61K39/08
- IPC: A61K39/08 ; C07K14/33 ; C07K16/12 ; A61K39/00
Abstract:
The invention provides methods, proteins, nucleic acids and antibodies for preventing or treating a C. difficile infection in a mammal.
Public/Granted literature
- US20150315248A1 CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE Public/Granted day:2015-11-05
Information query
